Medical Facilities Future Growth
Future criteria checks 0/6
Medical Facilities's revenue and earnings are forecast to decline at 14.3% and 30% per annum respectively while EPS is expected to decline by 29.1% per annum.
Key information
-30.0%
Earnings growth rate
-29.1%
EPS growth rate
Healthcare earnings growth | 58.0% |
Revenue growth rate | -14.3% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 15 Nov 2024 |
Recent future growth updates
Recent updates
Medical Facilities' (TSE:DR) Earnings Offer More Than Meets The Eye
Nov 15Medical Facilities (TSE:DR) Is Paying Out A Dividend Of $0.09
Jun 19We Think Medical Facilities' (TSE:DR) Robust Earnings Are Conservative
Mar 22Medical Facilities Corporation Just Reported A Surprise Loss: Here's What Analysts Think Will Happen Next
Nov 12Medical Facilities (TSE:DR) Seems To Use Debt Quite Sensibly
Aug 05Medical Facilities' (TSE:DR) Dividend Will Be $0.0805
Mar 26Medical Facilities (TSE:DR) Has Affirmed Its Dividend Of $0.0805
Dec 23Is Medical Facilities (TSE:DR) Using Too Much Debt?
Sep 14Is It Too Late To Consider Buying Medical Facilities Corporation (TSE:DR)?
May 13The Returns At Medical Facilities (TSE:DR) Aren't Growing
Apr 24Medical Facilities' (TSE:DR) Upcoming Dividend Will Be Larger Than Last Year's
Dec 21Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07
Sep 24Is Medical Facilities (TSE:DR) Using Too Much Debt?
Jul 24Medical Facilities (TSE:DR) Will Pay A Dividend Of CA$0.07
Jun 25Here's Why It's Unlikely That Medical Facilities Corporation's (TSE:DR) CEO Will See A Pay Rise This Year
May 07Is Now The Time To Look At Buying Medical Facilities Corporation (TSE:DR)?
Apr 19Here's How We Evaluate Medical Facilities Corporation's (TSE:DR) Dividend
Mar 29Medical Facilities (TSE:DR) Has A Somewhat Strained Balance Sheet
Mar 08Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 340 | N/A | N/A | N/A | 1 |
12/31/2025 | 338 | 13 | N/A | N/A | 2 |
12/31/2024 | 428 | 19 | N/A | N/A | 2 |
9/30/2024 | 441 | 20 | 74 | 81 | N/A |
6/30/2024 | 442 | 12 | 59 | 75 | N/A |
3/31/2024 | 445 | 16 | 63 | 78 | N/A |
12/31/2023 | 446 | 19 | 57 | 73 | N/A |
9/30/2023 | 443 | 5 | 52 | 70 | N/A |
6/30/2023 | 440 | -5 | 58 | 68 | N/A |
3/31/2023 | 433 | 8 | 56 | 64 | N/A |
12/31/2022 | 425 | -4 | 50 | 57 | N/A |
9/30/2022 | 416 | 8 | 58 | 63 | N/A |
6/30/2022 | 410 | 15 | 58 | 64 | N/A |
3/31/2022 | 405 | 4 | 59 | 67 | N/A |
12/31/2021 | 399 | 16 | 67 | 76 | N/A |
9/30/2021 | 395 | 2 | 67 | 75 | N/A |
6/30/2021 | 395 | 9 | 76 | 85 | N/A |
3/31/2021 | 365 | 4 | 112 | 118 | N/A |
12/31/2020 | 364 | 11 | 106 | 113 | N/A |
9/30/2020 | 371 | 36 | 101 | 109 | N/A |
6/30/2020 | 371 | 39 | 93 | 103 | N/A |
3/31/2020 | 397 | 62 | 61 | 72 | N/A |
12/31/2019 | 398 | 44 | 65 | 77 | N/A |
9/30/2019 | 367 | 31 | 63 | 78 | N/A |
6/30/2019 | 374 | 28 | 62 | 79 | N/A |
3/31/2019 | 387 | 11 | 59 | 80 | N/A |
12/31/2018 | 391 | 23 | 60 | 81 | N/A |
9/30/2018 | 420 | 23 | 63 | 83 | N/A |
6/30/2018 | 404 | 18 | N/A | 79 | N/A |
3/31/2018 | 394 | 25 | N/A | 85 | N/A |
12/31/2017 | 385 | 21 | N/A | 80 | N/A |
9/30/2017 | 382 | 38 | N/A | 79 | N/A |
6/30/2017 | 372 | 35 | N/A | 88 | N/A |
3/31/2017 | 353 | 15 | N/A | 76 | N/A |
12/31/2016 | 339 | 10 | N/A | 78 | N/A |
9/30/2016 | 321 | -5 | N/A | 82 | N/A |
6/30/2016 | 316 | 6 | N/A | 72 | N/A |
3/31/2016 | 312 | 9 | N/A | 82 | N/A |
12/31/2015 | 309 | 25 | N/A | 80 | N/A |
9/30/2015 | 301 | 8 | N/A | 84 | N/A |
6/30/2015 | 303 | 22 | N/A | 88 | N/A |
3/31/2015 | 300 | 39 | N/A | 86 | N/A |
12/31/2014 | 297 | 19 | N/A | 88 | N/A |
9/30/2014 | 305 | 33 | N/A | 92 | N/A |
6/30/2014 | 303 | 17 | N/A | 90 | N/A |
3/31/2014 | 306 | 9 | N/A | 84 | N/A |
12/31/2013 | 309 | 11 | N/A | 86 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: DR's earnings are forecast to decline over the next 3 years (-30% per year).
Earnings vs Market: DR's earnings are forecast to decline over the next 3 years (-30% per year).
High Growth Earnings: DR's earnings are forecast to decline over the next 3 years.
Revenue vs Market: DR's revenue is expected to decline over the next 3 years (-14.3% per year).
High Growth Revenue: DR's revenue is forecast to decline over the next 3 years (-14.3% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if DR's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/22 04:34 |
End of Day Share Price | 2024/12/20 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Medical Facilities Corporation is covered by 8 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Neil Maruoka | Canaccord Genuity |
Prakash Gowd | CIBC Capital Markets |
Douglas Loe | Echelon Wealth Partners Inc. |